HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Central PACAP mediates the sympathetic effects of leptin in a tissue-specific manner.

Abstract
We previously demonstrated that the peptidergic neurotransmitter pituitary adenylate cyclase-activating polypeptide (PACAP) affects the autonomic system and contributes to the control of metabolic and cardiovascular functions. Previous studies have demonstrated the importance of centrally-mediated sympathetic effects of leptin for obesity-related hypertension. Here we tested whether PACAP signaling in the brain is implicated in leptin-induced sympathetic excitation and appetite suppression. In anesthetized mice, intracerebroventricular (ICV) pre-treatment with PACAP6-38, an antagonist of the PACAP receptors (PAC1-R and VPAC2), inhibited the increase in white adipose tissue sympathetic nerve activity (WAT-SNA) produced by ICV leptin (2μg). In contrast, leptin-induced stimulation of renal sympathetic nerve activity (RSNA) was not affected by ICV pre-treatment with PACAP6-38. Moreover, in PACAP-deficient (Adcyap1-/-) mice, ICV leptin-induced WAT-SNA increase was impaired, whereas RSNA response was preserved. The reductions in food intake and body weight evoked by ICV leptin were attenuated in Adcyap1-/- mice. Our data suggest that hypothalamic PACAP signaling plays a key role in the control by leptin of feeding behavior and lipocatabolic sympathetic outflow, but spares the renal sympathetic traffic.
AuthorsM Tanida, A Hayata, N Shintani, N Yamamoto, Y Kurata, T Shibamoto, D A Morgan, K Rahmouni, H Hashimoto
JournalNeuroscience (Neuroscience) Vol. 238 Pg. 297-304 (May 15 2013) ISSN: 1873-7544 [Electronic] United States
PMID23454538 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Adcyap1 protein, mouse
  • Leptin
  • Peptide Fragments
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
  • pituitary adenylate-cyclase-activating-peptide (6-38)
Topics
  • Adipose Tissue, White (drug effects, innervation, metabolism)
  • Animals
  • Body Weight (drug effects)
  • Eating (drug effects)
  • Hypothalamus (drug effects, metabolism)
  • Injections, Intraventricular
  • Kidney (drug effects, innervation, metabolism)
  • Leptin (pharmacology)
  • Male
  • Mice
  • Mice, Knockout
  • Organ Specificity
  • Peptide Fragments (pharmacology)
  • Pituitary Adenylate Cyclase-Activating Polypeptide (genetics, metabolism, pharmacology)
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide (metabolism)
  • Sympathetic Nervous System (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: